We studied the effect of pravastatin on coronary perfusion after percutaneous, transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.
MANFRINI O, PIZZI C, MORGAGNI GL, FONTANA F, BUGIARDINI R. (2004). Effect of Pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty. THE AMERICAN JOURNAL OF CARDIOLOGY, 93(11), 1391-1393 [10.1016/j.amjcard.2004.02.037].
Effect of Pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty
MANFRINI, OLIVIA;PIZZI, CARMINE;FONTANA, FIORELLA;BUGIARDINI, RAFFAELE
2004
Abstract
We studied the effect of pravastatin on coronary perfusion after percutaneous, transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
